The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 42 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Vascular Endothelial Growth Factor A  [Clear All Filters]
Journal Article
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
Hostettler, K. E., Zhong J., Papakonstantinou E., Karakiulakis G., Tamm M., Seidel P., et al. (2014).  Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.. Respir Res. 15, 157.
Pentheroudakis, G., Kotoula V., Kouvatseas G., Charalambous E., Dionysopoulos D., Zagouri F., et al. (2014).  Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.. Clin Breast Cancer. 14(5), 330-8.
Lainas, T. G., & Kolibianakis E. M. (2015).  Authors' reply.. BJOG. 122(4), 585-6.
Koutras, A. K., Fountzilas G., Makatsoris T., Peroukides S., & Kalofonos H. P. (2010).  Bevacizumab in the treatment of breast cancer.. Cancer Treat Rev. 36(1), 75-82.
Masoura, S., Kalogiannidis I. A., Gitas G., Goutsioulis A., Koiou E., Athanasiadis A., et al. (2012).  Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.. J Obstet Gynaecol. 32(7), 609-16.
Masoura, S., Kalogiannidis I., Makedou K., Theodoridis T., Koiou K., Gerou S., et al. (2014).  Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.. Eur J Obstet Gynecol Reprod Biol. 175, 119-23.
Dambala, K., Paschou S. A., Michopoulos A., Siasos G., Goulis D. G., Vavilis D., et al. (2019).  Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome.. Angiology. 70(9), 797-801.
Giannakoulas, G., Mouratoglou S-A., Gatzoulis M. A., & Karvounis H. (2014).  Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.. Int J Cardiol. 174(3), 618-23.
Sakellariou, G. T., Anastasilakis A. D., Bisbinas I., Oikonomou D., Gerou S., Polyzos S. A., et al. (2015).  Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.. Rheumatology (Oxford). 54(5), 908-14.
Zarogoulidis, P., Pavlioglou P., Le Pivert P., Machairiotis N., Katsikogiannis N., Kougioumtzi I., et al. (2014).  Current and future intratumoral targeted treatment for pancreatic cancer.. Ther Deliv. 5(8), 913-26.
Stergiou, P. K., Symeonidis C., & Dimitrakos S. A. (2011).  Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization.. Acta Ophthalmol. 89(3), 218-21.
Symeonidis, N., Papakonstantinou E., Psarras K., Ballas K., Pavlidis T., Karakiulakis G., et al. (2014).  The effect of celecoxib administration on the healing and neovascularization of colonic anastomosis in rats.. J Invest Surg. 27(3), 139-46.
Mandalos, A., Tsakpinis D., Karayannopoulou G., Tsinopoulos I., Karkavelas G., Chalvatzis N., et al. (2010).  The effect of subconjunctival ranibizumab on primary pterygium: a pilot study.. Cornea. 29(12), 1373-9.
Sokolakis, I., Dimitriadis F., Psalla D., Karakiulakis G., Kalyvianakis D., & Hatzichristou D. (2019).  Effects of low-intensity shock wave therapy (LiST) on the erectile tissue of naturally aged rats.. Int J Impot Res. 31(3), 162-169.
Liontos, M., Trigka E-A., Korkolopoulou P., Tzannis K., Lainakis G., Koutsoukos K., et al. (2017).  Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.. World J Urol. 35(3), 411-419.
Pectasides, D., Papaxoinis G., Kotoula V., Fountzilas H., Korantzis I., Koutras A., et al. (2012).  Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.. Oncol Rep. 27(1), 216-24.
Psoma, E., Koliou G-A., Dimitrakopoulos F-I., Papadopoulou K., Rontogianni D., Bobos M., et al. (2020).  Genetic Variations of Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.. Anticancer Res. 40(2), 677-688.
Triantafyllou, A., Anyfanti P., Triantafyllou G., Zabulis X., Aslanidis S., & Douma S. (2016).  Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals.. J Am Soc Hypertens. 10(8), 640-6.
Zarogoulidis, P., Katsikogianni F., Tsiouda T., Sakkas A., Katsikogiannis N., & Zarogoulidis K. (2014).  Interleukin-8 and interleukin-17 for cancer.. Cancer Invest. 32(5), 197-205.
Mataftsi, A., Dimitrakos S. A., & Adams G. G. W. (2011).  Mediators involved in retinopathy of prematurity and emerging therapeutic targets.. Early Hum Dev. 87(10), 683-90.
Almaliotis, D., Koliakos G., Papakonstantinou E., Komnenou A., Thomas A., Petrakis S., et al. (2015).  Mesenchymal stem cells improve healing of the cornea after alkali injury.. Graefes Arch Clin Exp Ophthalmol. 253(7), 1121-35.
Toulis, K. A., Goulis D. G., Mintziori G., Kintiraki E., Eukarpidis E., Mouratoglou S-A., et al. (2011).  Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.. Hum Reprod Update. 17(6), 741-60.
Kitsou, C., Kosmas I., Lazaros L., Hatzi E., Euaggelou A., Mynbaev O., et al. (2014).  Ovarian hyperstimulation syndrome inhibition by targeting VEGF, COX-2 and calcium pathways: a preclinical randomized study.. Gynecol Endocrinol. 30(8), 587-92.
Fountzilas, G., Fragkoulidi A., Kalogera-Fountzila A., Nikolaidou M., Bobos M., Calderaro J., et al. (2010).  A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.. Cancer Chemother Pharmacol. 65(4), 649-60.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.